Visium Asset Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,271
Closed -$81K 60
2016
Q2
$81K Sell
1,271
-16,570
-93% -$1.06M 0.01% 284
2016
Q1
$1.78M Sell
17,841
-3,259
-15% -$325K 0.03% 372
2015
Q4
$3.27M Hold
21,100
0.05% 313
2015
Q3
$4.29M Hold
21,100
0.06% 288
2015
Q2
$5.82M Sell
21,100
-4
-0% -$1.1K 0.08% 261
2015
Q1
$5.07M Hold
21,104
0.07% 259
2014
Q4
$5.4M Buy
21,104
+5,429
+35% +$1.39M 0.08% 202
2014
Q3
$4.56M Buy
+15,675
New +$4.56M 0.07% 252